Environmental triggers of thyroiditis: hepatitis C and interferon-α. (Q37836257)

24 August 2017

1 reference

title

Environmental triggers of thyroiditis: hepatitis C and interferon-α. (English)

1 reference

24 August 2017

1 reference

F Menconi

1

1 reference

24 August 2017

A Hasham

series ordinal

2

1 reference

24 August 2017

Y Tomer

series ordinal

3

1 reference

24 August 2017

language of work or name

1 reference

28 February 2010

1 reference

Journal of Endocrinological Investigation

24 August 2017

1 reference

24 August 2017

34

1 reference

24 August 2017

78-84

1 reference

24 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03346699

24 August 2017

0 references

cites work

Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms.

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Iodine: an environmental trigger of thyroiditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Modifying effects of iodine on the immunogenicity of thyroglobulin peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Interferon induced Autoimmune Thyroid Disease (AITD): a model for human autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Infections and autoimmune endocrine disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

The etiology of autoimmune thyroid disease: a story of genes and environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Interferon Alpha Treatment and Thyroid Dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Environmental triggers of autoimmune thyroiditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Hypothyroidism in Workers Exposed to Polybrominated Biphenyls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Viruses and thyroiditis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Interferon-alpha and autoimmune thyroid disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Sex steroid regulation of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

'Linkage analysis of thyroid antibody production: evidence for shared susceptibility to clinical autoimmune thyroid disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

The effects of alpha interferon on the development of autoimmune thyroiditis in the NOD H2h4 mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Hepatitis C and thyroid autoimmunity: is there a link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Thyroid disorders in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Prevalence and significance of thyroid autoantibodies in patients with chronic hepatitis C virus infection: a prospective controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Is hepatitis C virus a risk factor for thyroid autoimmunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Thyroid dysfunction in hepatitis C individuals treated with interferon-alpha and ribavirin--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Autoimmune thyroid dysfunction induced by interferon-alpha treatment for chronic hepatitis C: screening and monitoring recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Thyroid disorders in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Virologic factors related to interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

HCV E2 protein binds directly to thyroid cells and induces IL-8 production: A new mechanism for HCV induced thyroid autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Interferon induced thyroiditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Side effects of therapy for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Adverse effects of drugs in the treatment of viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Type I interferons modulate the expression of thyroid peroxidase, sodium/iodide symporter, and thyroglobulin genes in primary human thyrocyte cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Effect of type I interferon(s) on cell viability and apoptosis in primary human thyrocyte cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Mechanism of action of interferon and ribavirin in treatment of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Biologic responses to IFN-alpha administration in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Type I interferons and T helper development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Signal transducer and activator of transcription (Stat)-6-dependent, but not Stat4-dependent, immunity is required for the development of autoimmunity in Graves' hyperthyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Innate and acquired immune system in patients developing interferon-alpha-related autoimmune thyroiditis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Prevention of autoantibody-mediated Graves'-like hyperthyroidism in mice with IL-4, a Th2 cytokine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Autoimmune aspects of cytokine and anticytokine therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Enhancement by interferon of the expression of surface antigens on murine leukemia L 1210 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Longitudinal study of antibodies against thyroid in patients undergoing interferon-alpha therapy for HCV chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Clinical review 169: Interferon-alpha-related thyroid disease: pathophysiological, epidemiological, and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Interferon-alpha-induced hyperthyroidism: a three-stage evolution from silent thyroiditis towards Graves' disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Hepatitis C: thyroid dysfunction in patients with hepatitis C on IFN-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346699

Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C

21 January 2018

1 reference

12 December 2020

Expression of ICAM-1, B7.1 and TPO on human thyrocytes induced by IFN-alpha

1 reference

12 December 2020

Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts

1 reference

12 December 2020

The swinging thyroid in hepatitis C infection and interferon therapy

1 reference

12 December 2020

Thyrotoxicosis induced by alpha-interferon therapy in chronic viral hepatitis

1 reference

12 December 2020

Long-term outcome of interferon-alpha-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment

1 reference

12 December 2020

Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons.

1 reference

12 December 2020

Intrathyroidal cytokine gene expression in Hashimoto's thyroiditis

1 reference

12 December 2020

Hashimoto's disease during interferon-alpha therapy in a patient with pre-treatment negative anti-thyroid autoantibodies and with the specific genetic susceptibility to the thyroid disease

1 reference

12 December 2020

Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy

1 reference

12 December 2020

Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control study

1 reference

12 December 2020

Effects of interferon-alpha (IFN-alpha) administration on leucocytes in healthy humans

1 reference

12 December 2020

Interferon-gamma induces HLA-DR expression by thyroid epithelium

1 reference

12 December 2020

Autoimmune endocrine disease induced by recombinant interferon-alpha therapy for chronic active type C hepatitis

1 reference

12 December 2020

HLA antigens in patients with interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C

1 reference

12 December 2020

The risk factor for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C

1 reference

12 December 2020

Dissecting genetic heterogeneity in autoimmune thyroid diseases by subset analysis

1 reference

12 December 2020

Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa

1 reference

12 December 2020

PRIMARY HYPOTHYROIDISM ASSOCIATED WITH INTERFERON THERAPY OF BREAST CANCER

1 reference

12 December 2020

Thyroid gland dysfunctions during antiviral therapy of chronic hepatitis C.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03346699

1 reference

24 August 2017

1 reference